FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024199213> ?p ?o ?g. }

• W2024199213 endingPage "702" @default.
• W2024199213 startingPage "697" @default.
• W2024199213 abstract "Background: Advanced cancers frequently metastasize to bone, and the presence of bone metastases is the most common cause of cancer-related pain. Pain management requires a multidisciplinary approach that involves the use of analgesics, bisphosphonates, radiotherapy, chemotherapy, surgery. The aim of our study was to evaluate the enhancement of radiotherapy on painful bone metastases in patients treated also with bisphosphonates. Materials and Methods: We analyzed the differences in benefit on pain and on quality of life comparing two groups of treatment. The first group comprised 104 patients treated with Radiotherapy (RT), the second one included 50 patients treated with radiotherapy associated to zoledronic acid (RT + Z). All patients completed before, during and after treatment, a questionnaire that rated the grade of pain, the pharmacological type of analgesic therapy and patient’s performance status. For each patient a total score was calculated, from a minimum value of 0% to a maximum of 20%, then expressed as a percentage. Patients were classified as responder if at the follow-up reported a reduction of over 20% of the initial score, no-change if there was a reduction of between 0% and 20%, progression if there was an increasing of the score. Results: In the group RT + Z we found fewer patients that started radiation therapy with severe pain (16% vs 32%), no patient had pain of grade 10, and a higher proportion of asymptomatic patients (12% vs 4%) was observed. In the RT alone group a higher percentage of patients started treatment assuming strong opioid more than once a day (26% vs 24%) and a reduction in number of these patients was about 14% compared with the reduction of 23.6% observed in the group RT + Z. Furthermore an increased total score was calculated only in the 6% of patient belonged to group RT alone. Finally, in the group RT + Z responder patients are 52%, compared to 36% of the RT group, non-responder were 36% versus 60% in the RT. The risk of adverse events (Pz) in the RT + Z was Pz = 0.36, with an odds (Oz) equal to 0.56, while the risk of adverse events (Pc) in the RT group was Pc = 0.60 with an odds (OC) of 1.5. The odds ratio was OR = 0.37, showing a value in favor of treatment RT + Z. Conclusions: In our retrospective observational study it is relevant a clear potentiation of benefit effects related to palliative radiation therapy in patients receiving also bisphosphonate therapy, so obtaining a better control over pain, a decreased need for pain relief and consequently an improved quality of life." @default.
• W2024199213 created "2016-06-24" @default.
• W2024199213 creator A5013735269 @default.
• W2024199213 creator A5037033641 @default.
• W2024199213 creator A5038532224 @default.
• W2024199213 creator A5054167828 @default.
• W2024199213 creator A5070279858 @default.
• W2024199213 creator A5076904960 @default.
• W2024199213 creator A5081192064 @default.
• W2024199213 date "2011-01-01" @default.
• W2024199213 modified "2023-10-16" @default.
• W2024199213 title "Management of Painful Bone Metastases: The Interaction between Radiation Therapy and Zoledronate" @default.
• W2024199213 cites W1521095066 @default.
• W2024199213 cites W1944967894 @default.
• W2024199213 cites W1989014251 @default.
• W2024199213 cites W1994309595 @default.
• W2024199213 cites W1996072079 @default.
• W2024199213 cites W2000144084 @default.
• W2024199213 cites W2000647744 @default.
• W2024199213 cites W2017654113 @default.
• W2024199213 cites W2037098010 @default.
• W2024199213 cites W2041868422 @default.
• W2024199213 cites W2051464033 @default.
• W2024199213 cites W2053925700 @default.
• W2024199213 cites W2062271329 @default.
• W2024199213 cites W2063795982 @default.
• W2024199213 cites W2077101439 @default.
• W2024199213 cites W2088438928 @default.
• W2024199213 cites W2088648008 @default.
• W2024199213 cites W2106766464 @default.
• W2024199213 cites W2109360630 @default.
• W2024199213 cites W2119263434 @default.
• W2024199213 cites W2126121630 @default.
• W2024199213 cites W2137083298 @default.
• W2024199213 cites W2159646703 @default.
• W2024199213 cites W2280162642 @default.
• W2024199213 cites W2418904322 @default.
• W2024199213 cites W2474781669 @default.
• W2024199213 doi "https://doi.org/10.4236/jct.2011.25094" @default.
• W2024199213 hasPublicationYear "2011" @default.
• W2024199213 type Work @default.
• W2024199213 sameAs 2024199213 @default.
• W2024199213 citedByCount "2" @default.
• W2024199213 countsByYear W20241992132014 @default.
• W2024199213 countsByYear W20241992132016 @default.
• W2024199213 crossrefType "journal-article" @default.
• W2024199213 hasAuthorship W2024199213A5013735269 @default.
• W2024199213 hasAuthorship W2024199213A5037033641 @default.
• W2024199213 hasAuthorship W2024199213A5038532224 @default.
• W2024199213 hasAuthorship W2024199213A5054167828 @default.
• W2024199213 hasAuthorship W2024199213A5070279858 @default.
• W2024199213 hasAuthorship W2024199213A5076904960 @default.
• W2024199213 hasAuthorship W2024199213A5081192064 @default.
• W2024199213 hasBestOaLocation W20241992131 @default.
• W2024199213 hasConcept C121608353 @default.
• W2024199213 hasConcept C126322002 @default.
• W2024199213 hasConcept C141071460 @default.
• W2024199213 hasConcept C159110408 @default.
• W2024199213 hasConcept C2776139714 @default.
• W2024199213 hasConcept C2776326535 @default.
• W2024199213 hasConcept C2776694085 @default.
• W2024199213 hasConcept C2777783956 @default.
• W2024199213 hasConcept C2777910003 @default.
• W2024199213 hasConcept C2779013556 @default.
• W2024199213 hasConcept C2779951463 @default.
• W2024199213 hasConcept C2780820201 @default.
• W2024199213 hasConcept C42219234 @default.
• W2024199213 hasConcept C509974204 @default.
• W2024199213 hasConcept C71924100 @default.
• W2024199213 hasConceptScore W2024199213C121608353 @default.
• W2024199213 hasConceptScore W2024199213C126322002 @default.
• W2024199213 hasConceptScore W2024199213C141071460 @default.
• W2024199213 hasConceptScore W2024199213C159110408 @default.
• W2024199213 hasConceptScore W2024199213C2776139714 @default.
• W2024199213 hasConceptScore W2024199213C2776326535 @default.
• W2024199213 hasConceptScore W2024199213C2776694085 @default.
• W2024199213 hasConceptScore W2024199213C2777783956 @default.
• W2024199213 hasConceptScore W2024199213C2777910003 @default.
• W2024199213 hasConceptScore W2024199213C2779013556 @default.
• W2024199213 hasConceptScore W2024199213C2779951463 @default.
• W2024199213 hasConceptScore W2024199213C2780820201 @default.
• W2024199213 hasConceptScore W2024199213C42219234 @default.
• W2024199213 hasConceptScore W2024199213C509974204 @default.
• W2024199213 hasConceptScore W2024199213C71924100 @default.
• W2024199213 hasIssue "05" @default.
• W2024199213 hasLocation W20241992131 @default.
• W2024199213 hasOpenAccess W2024199213 @default.
• W2024199213 hasPrimaryLocation W20241992131 @default.
• W2024199213 hasRelatedWork W2153528246 @default.
• W2024199213 hasRelatedWork W2350913948 @default.
• W2024199213 hasRelatedWork W2355417594 @default.
• W2024199213 hasRelatedWork W2356732384 @default.
• W2024199213 hasRelatedWork W2357364763 @default.
• W2024199213 hasRelatedWork W2360420010 @default.
• W2024199213 hasRelatedWork W2388013030 @default.
• W2024199213 hasRelatedWork W2404106007 @default.
• W2024199213 hasRelatedWork W3028642342 @default.
• W2024199213 hasRelatedWork W3032493634 @default.

• next